www.gavi.org
TECHNICAL UPDATE:
POLIO ERADICATION AND ROUTINE
IMMUNIZATION STRENGTHENING
Gavi Board pre -meeting
December 9, 2014, Geneva

SESSION OUTLINE
? Global polio eradication update
? Overview of Polio Endgame Strategic
Objective 2:
? IPV introduction and OPV withdrawal
? RI strengthening in polio focus countries
? Specific implications for Gavi

2 #add your hashtag

Gavi

GAVI pre -Board Technical Update
UNICEF Supply Division
9 December, 2014
Programme Group
Deputy Exec Director,
Geeta Rao Gupta
Programme
Division
Ted Chaiban
Emergencies
Afshan Khan
Supply
Shanelle Hall
Partnerships Group
Deputy Exec Director
Yoka Brandt
Division of
Communication
Paloma Escudero
Public Partnerships
Olav Kjorvan
Policy & Research
Jeff O'Malley
Private Sector
Partnerships
Gerard Bocquenet
Management Group
Dep Exec Directoe
Martin Mogwanja
Financial
Management &
Admin
(incoming)
Human Resources
Richard Bridle
IT
(incoming)
Global Service
Centre
Field Results Group
Dep Exec Director
Omar Abdi
Regional Directors (7)
Country Offices
Supply in the UNICEF structure
2
Executive Director
Anthony Lake

Gov -2012 -Mtg -4-Doc 00b




GAVI Alliance Board Meeting
10 -11 December 2014
Starling Hotel, Geneva, Switzerland

Tuesday 9 December: Pre -Board meetings
Wednesday 10 December : 0 9.00 -18.00 (Board meeting Day One)
Thursday 11 December : 0 8.30 -17.30 (Board meeting Day Two)
Quorum: 14

Document list
No. Document
00a Document list
00b Agenda
01a Declarations of interest
01b Minutes from 18-19 June 2014
01c Workplan
01 d Board attendance
02a Consent agenda: Board/Committee member nominations (To follow)
02b Consent agenda : Vice Chair nomination (To follow)
02c Consent agenda: Committee Chair appointments (To follow)
02d Consent agenda: Appointment of Independent Auditor for 2014 -2018
03 CEO?s report (To follow)
04 Committee Chair and IFFIm Board reports ? No paper
05 Accelerating access to Ebola vaccines and country perspective
06 Chair?s reflections on the day ? No paper
07 Chair?s overview & presentation of film ? No paper
08 The road to replenishment 2016 -2020
09 Financial forecast and 2015 programme funding env elope approval s
10 Country Programmes strategic issues
11 IPV in India (To follow)
12 Gavi risk policy, risk management & fiduciary oversight
13 2015 Business plan and budget
14 Review of decisions ? No paper
15 Any other business ? No paper

Additional Documents for Informati on
A Annual report on the i mplementation of the Gender Policy
B Board and Committee minutes (For information only)

Board -2014 -Mtg -3-Doc 00b




GAVI Alliance Board Meeting
10 -11 December 2014
Starling Hotel, Geneva, Switzerland

Tuesday 9 December: Pre -Board meetings
Wednesday 10 December : 0 9.00 -18.00 (Board meeting Day One)
Thursday 11 December : 0 8.30 -17.30 (Board meeting Day Two)
Quorum: 14


Agenda


Pre -Board Meetings ? Tuesday , 9 December 2014
Item Subject Room Schedule

Pre -Board meetings
? Technical Briefing Session
o Finance update
o UNICEF Supply Division
Break
o Polio and strengthening routine immunisation
o Private sector engage ment framework
Nendaz 08. 45 -13.00
08.45 -09.45
09.45 -10.45
10.45 -11.00
11.00 -12.00
12.00 -13.00
? GAVI Donors? meeting Leysin 13. 30 -15. 15
? Unaffiliated Board members meeting Arosa 14. 30-15. 30
? Developing Countries Board members meeting Montana 14.45 -16.45
? IFFIm Donors? meeting Villars 15.15 -16.45
? Governance Committee meeting Arosa 17.00 -19.00
? Board Chair dinner with new Board members 20.00

Board -2014 -Mtg -3-Doc 01 a




GAVI Alliance Board Meeting
10 -11 December 2014
Starling Hotel, Geneva, Switzerland

Tuesday 9 December: Pre -Board meetings
Wednesday 10 December : 0 9.00 -18.00 (Board meeting Day One)
Thursday 11 December : 0 8.30 -17.30 (Board meeting Day Two)
Quorum: 14

Declarations of Interest

Declarations
Section 5.2 of the Conflict of Interest Policy states, ?Annually, each member of the Board
(including alternate Board members and Committee delegates)...shall complete and submit
a conflict of interest for m to be distributed by the Managing Director, Law and Governance.?
The following declarations were made by members of the Investment Committee on their
most recent annual statements:
Member Org anisational Interest s Financial/Personal/Advisor Int
Dagfinn H?ybr?ten , Chair None GAVI -appointed special adviser
Geeta Rao Gupta , Vice
Chair None GAVI -appointed special adviser
Joan Awunyo -Akaba Future Generations International
(CSOs)
GAVI -appointed special adviser/
Jansen through Dev -Pro Consultin g
Wayne Berso n None None
Zulfiqar Bhutta
Aga Khan University, Pakistan
(Research & Tech. Health
Institutes)
None
Donal Brown UK ( UK/ CA N/IRL ) None
Flavia Bustreo WHO None
Olivier Charmeil Int?l Fed. of Pharma. Manu. &
Assoc .Dev. Sanofi Pasteur (Employee) /TBD
Awa Marie Coll -Seck Government of Senegal GAVI -appointed special
adviser /TBD
H.R.H. the Infanta
Cristina of Spain None
GAVI -appointed special advis er
?la Caixa? Foundation (Employee)
Barcelona Inst. for Global Health (Board)
Aga Khan Development Network
(Employee)
Jenny Da Rin DFAT (AUS/JPN/KOR /US ) None
Suraya Dalil Government of Afghanistan GAVI -appointed special
advis er/TBD
Tim Evans World Bank None
Maria C. Freire None
Johns Hopkins (Family)
Barcelona Inst. For Global
Health

GAVI Alliance Board Meeting
18 -19 June 2014
Board -2014 -Mtg -2 1




GAVI Alliance Board Meeting
18-19 June 2014
Geneva, Switzerland


FINAL M INUTES


1. Chair?s report

1.1 Finding a quorum of members present, the meeting commenced at 11.15
local time on 18 June 2014. Dagfinn H?ybr?ten, Board Chair, chaired the
meeting.

1.2 The Chair noted that as a result of the Board and Committee self -assessment
in 2014 , the Board decided at its April 2014 retreat to be more efficient and
strategic as a B oard. For example, to allow for more time for free -flowing
discussion and debate around the Board table, the Board agenda contain ed
fewer separate information items with technical sessions available the day
before the Board. He was pleased to note that tho se sessions were well
attended with good feedback from Board members.

1.3 The Chair welcomed incoming Board members, noting that he had hosted a
dinner for new Board members and alternates the previous evening . He noted
that several Board members and alternates were departing from the Board
and they were thanked for their contributions to the GAVI Alliance. He also
welcomed Ren? Karsenti, the IFFIm Chair, and his fellow IFFIm directors to
the meeting.

1.4 The Chai r welcomed Anuradha Gupta, incoming Deputy CEO to her first
Board meeting, noting that the Board members looked forward to working with
her. This also meant saying goodbye to Helen Evans, Deputy CEO . The
Board would have an opportunity to recognise her sub stantial contribution to
the GAVI Alliance during the Board dinner that evening.

1.5 Standing declarations of interest were tabled to the Committee (Doc 1a in the
Committee pack). The Board noted its minutes from 21 -22 November 2013
(Doc 01b) and 8 April 2014 (Doc 01c), which were approved by no objection
on 25 February 2014 and 30 May 2014, respectively. It also noted its act ion
sheet (Doc 01d) and workplan (Doc 01e).

1.6 Finally, the Chair invited the Board to view a film reviewing the successful
replenishment launch meeting held in Brussels on 20 May 2014.

BOARD WORK PLAN
Graphical format

Board -2014 -Mtg -3-Doc 01c








GAVI Alliance Board Agendas
FOR BOARD DECISION
Board/Cte member appointments (Consent Agenda)
Board Chair appointment
Cte chair appointments (Consent Agenda)
Statutes and By-law changes (Consent Agenda)
Changes to Committee Charters (Consent Agenda)
Review of eligiblity, graduation and co-financing policies
GAVI support for access to appropriate pricing for GAVI graduates & other lower middle income
countries
Gavi support for measles second dose
Gavi Alliance Strategy 2016-2020 - goal level indicators
Vaccine introduction grant & operational support for campaigns policy review
Supply and procurement strategy
Data strategy
HSS resource allocation options
Financial forecast [and programme funding envelope approval]
Business plan and budget
Annual financial report
Chair rpt (Decl of Int, Mins, Acts, W kpl)
CEO report
Committee chair reports
IFFIm report
Risk management update
Resource Mobilisation update
Review of decisions and actions
Any other business
Report of the internal auditor
Decision
Decision
Information
Decision
Decision
Decision
Decision
Discussion
Discussion
Information
Information
Information
Information
Information
N/A
Oct-Nov 2015 2-3 Dec 2015
Decision
Decision
Decision
Decision
Decision
Sept 2015 NoObj
Decision
July-Aug 2015
Information
Discussion
N/A
Information
Information
Information
Information
Information
Decision
Jan-Feb 2015 24-25 Mar 2015 Apr-May 2015 10-11 June 2015
Decision
Discussion
Decision
Decision
STANDING REPORTS ONCE PER YEAR
STANDING REPORTS AT EACH REGULAR MEETING
Decision
18 Sept 2015
Decision

Board Members 14-Jun Retreat 14 Nov-13 Jun-14 Retreat 13 Dec-12 Jun-12 Retreat 12 Tel Apr 12 Nov-11 Jul-11 Retreat 11 Tel Mar 11 Nov-10 Tel Aug 10 Jun-10 Retreat 10 Tel Apr 10 Tel Mar 10
INDEPENDENT INDIVIDUALS
Dagfinn H?ybr?ten Attend Attend Attend Attend Attend Attend Attend Attend Attend Attend Attend Attend Attend Attend Attend Attend Regrets ** Attend Attend
Wayne Berson Attend Attend Regrets Attend Regrets Attend Attend Attend Attend Regrets Attend Attend Regrets Attend Regrets Attend Attend Attend Attend
Stephen Zinser Attend
George W. Wellde Attend Attend Attend Regrets Attend Attend Attend Attend Attend Attend Attend Attend Regrets Attend Attend Attend Regrets ** Attend Attend
Ashutosh Garg Attend Attend Attend Attend Attend Attend Attend Attend Attend Attend Attend Attend Attend Attend Regrets Attend Regrets ** Regrets Attend
Maria C Freire Attend Attend Attend Attend Regrets Regrets Attend Attend
HRH Infanta Cristina Attend Attend Attend Attend Attend Attend Attend Regrets
Yifei Li Attend Attend Attend Attend Attend Attend Attend Attend
Richard Sezibera Attend Attend Attend Attend Attend Attend
GATES FOUNDATION
Orin Levine Attend Attend Attend Attend Attend
Steve Landry (Alt.) Attend Attend Attend Attend Attend Attend Attend Attend Attend
WORLD BANK
Tim Evans Attend Attend Attend
Armin Fidler (Alt.) Regrets Attend Attend Attend Attend Attend Attend Regrets Attend Regrets Regrets Attend Attend Regrets Regrets Regrets Regrets
UNICEF
Geeta Rao Gupta Attend Regrets Attend Attend Attend Attend Attend Attend Regrets Attend Attend
Shanelle Hall (Alt.) Attend Attend
WHO
Flavia Bustreo Attend Regrets Regrets Attend Attend Attend Attend Attend Attend Attend Attend Regrets Attend
Jean-Marie Okwo-Bele (Alt.) Regrets Attend Attend Attend Attend Attend Attend Attend Attend Attend Attend Attend Attend Attend
GOV'T-DEVELOPING COUNTRIES
Ruhakana Rugunda Attend Attend Attend
Seif Rashidi (Alt.) Attend
A.F.M. Ruhal Haque Attend Attend Regrets Regrets Attend Attend Attend Attend Attend
Pe Thet Khin (Alt.) Attend Regrets Regrets Regrets Attend Attend
Suraya Dalil Attend Regrets Regrets Regrets Regrets Attend Attend Attend Attend
Salah Banoita Tourab (Alt.) Attend Attend Regrets Attend Attend Attend Regrets Attend
Awa Marie Coll-Seck Attend Regrets Regrets Attend Regrets Attend
Dorothee Kinde Gazard (Alt.) Regrets Regrets Regrets Regrets Attend Attend
Andrei Usatii Attend Regrets Attend Attend Attend
Bheri Ramasaran Regrets Regrets Attend
GOV'T-INDUSTRIALISED COUNTRIES
Walter Seidel Attend Attend Attend
Emmanuel Lebrun-Damiens (alt) Attend Attend Attend
Angela Santoni Attend Attend Attend Attend Attend Attend Attend Attend Attend
Javier Hern?ndez Pe?a (Alt.) Attend
Anders Nordstr ?m Attend Regrets Attend Attend Attend Attend Attend Attend Attend Attend Attend Attend Regrets
Beate Stir? (Alt.) Attend Attend Attend
Donal Brown Attend Attend Attend
Micheline Gilbert (Alt.) Regrets Attend Attend Attend Attend
Jenny Da Rin Attend Attend Attend
Robert Clay (Alt.) Attend Attend Attend
VACCINE INDUSTRY-INDUSTRIALISED COUNTRIES
Johan Van Hoof Attend Regrets Regrets Attend Attend Regrets Attend Attend
Olga Popova (Alt.) Attend Regrets Regrets Regrets Attend Attend Attend Attend Attend Attend Attend
VACCINE INDUSTRY-DEVELOPING COUNTRIES
Mahima Datla Attend Attend Attend Regrets Regrets Attend Attend Attend Regrets Attend Attend
Juliman Fuad (Alt.) Attend Regrets Attend
CIVIL SOCIETY ORGANISATIONS
Joan Awunyo-Akaba Attend Attend Attend
Naveen Thacker Attend Attend Attend
RESEARCH AND TECHNICAL HEALTH INSTITUTES
Zulfiqar Bhutta Attend Regrets Attend Attend Attend
Samba Sow Attend Regrets Attend Attend Regrets
GAVI CEO
Seth Berkley, MD Attend Attend Attend Attend Attend Attend Attend Attend Attend Attend
**Retreat rescheduled from April to May due to Icelandic volcano
Board-2014-Mtg-3-Doc 01d

1



Board -2014 -Mtg -3-Doc 02a
Report to the Board
10 -11 December 2014


Section A: Overview
Purpose of the report 1.
1.1 This report sets out recommendations for Board and committee
membership.
1.2 The Governance Committee will meet on 9 December to review
nominations received which are on the Consent Agenda for the Board
meeting .
Recommendations 2.
2.1 On 9 December 2014, t he Governance Committee will consider
recommending to the Board that it :
a) Appoint the following Board Members:
? David Sidwell as an Unaffiliated Board Member in the seat
currently held by George W. Wellde, Jr effective 1 January 2015
and until 31 December 2017
? Gunilla Carlsson as an Unaffiliated Board Member in the seat
currentl y held by Ashutosh Garg effective 1 January 2015 and until
31 December 2017
? Seif Seleman Rashid of Tanzania as Board Member representing
the developing country constituency in the seat currently held by
Ruhakana Rugunda of Uganda effective 1 January 2015 and until
31 December 2017
SUBJECT : CONSENT AGENDA: BOAR D/COMMITTEE MEMBER
NOMINATIONS
Report of: Debbie Adams, Managing Director, Law and Governance
Authored by: Kevin A. Klock, Head of Governance and Assistant Secretary
Agenda item: 02 a
Category: For Decision
Strategic goal: Alliance operations

1



Board -2014 -Mtg -3-Doc 02b
Report to the Board
10 -11 December 2014


Section A: Overview
Purpose of the report 1.
1.1 This report reviews the process to nominate the Board Vice Chair.
1.2 The Governance Committee will meet on 9 December to review
nominations received which are on the Consent Agenda for the Board
meeting.
Recommendations 2.
2.1 On 9 December, t he Governance Committee will consider recommending
to the Board that it :
a) Appoint Flavia Bustreo as Vice Chair of the Board with individual
signatory authority effective 1 January 2015 and until 31 December
2016.
At the Board meeting, the minutes will note that Flavia Bustreo did not
participate in discussion and voting on her appointm ent.
Executive summary 3.
Process
3.1 On 9 September 2014, Geeta Rao Gupta sent an email to the Board Chair
informing him that she would step down as Vice Chair effective 31
December 2014. The Chair notified the Board of Dr Rao Gupta?s decision
on 24 September an d invited nominations for Dr Rao Gupta?s successor to
be submitted to him by 31 October.
SUBJECT : CONSENT AGENDA: VICE CHAIR NOMINATION
Report of: Debbie Adams, Managing Director, Law and Governance
Authored by: Kevin A. Klock, Head of Governance and Assistant Secretary
Agenda item: 02 b
Category: For Decision
Strategic goal: Alliance operations

1



Board -2014 -Mtg -3-Doc 02c
Report to the Board
10 -11 December 2014


Section A: Overview
Purpose of the report 1.
1.1 This report outlines recommendations for committee chairships.
1.2 The Governance Committee will meet on 9 December to review
nominations received which are on the Consent Agenda for the Board
meeting.
Recommendations 2.
2.1 On 9 December 2014, t he Governance Committee will consid er
recommending to the Board th at it :
a) Appoint the following committee chairs:
? Stephen Zinser as Chair of the Investment Committee effective 1
January 2015 until 31 December 2015
? Rob Moodie as Chair of the Evaluation Advisory Committee
effective 1 January 2015 until 31 December 2016.
b) Re ppoint the foll owing:
? Wayne Berson as Chair of the Audit and Finance Committee until
31 December 2015.
SUBJECT : CONSENT AGENDA: COMM ITTEE CHAIR APPOINTM ENTS
Report of: Debbie Adams, Managing Director, Law and Governance
Authored by: Kevin A. Klock, Head of Governance and Assistant Secretary
Agenda item: 02 c
Category: For Decision
Strategic goal: Alliance operations

1



Board -2014 -Mtg -3-Doc 03


3 December 2014
Dear Board members
Eight months ago, we met in Berlin for a pivotal Board Retreat to debate the
building blocks of Gavi?s 2016 -20 strategy. In eight weeks ? time , another meeting
in Berlin will determine whether the Alliance is fully funded to deliver on that
strategy. Whe n Gavi?s history is written, the se two meetings in the German
capital may be seen as the defining moments of this period .
There has of course been a huge amount achieved between those meetings. In
2014, we saw the 73 rd ? and final ? Gavi country launch pentavalent vaccine; we
achieved our vaccine intro duction targets for this strategy period for pentavalent,
pneumococcal and rotavirus vaccines; we saw nearly every Gavi country apply
for inactivated polio vaccine (IPV) support; we reached more children than ever
before with routine immunisation; we saw r ecord levels of co -financing; we
achieved the lowest weighted average price ever for our main three vaccines ; we
agreed on our 2016 -20 strategy framework; and we made great strides to being
fully replenished. We also continue to work hard to address the ma jor challenges
we face including coverage and equity of immunisation, challenging political
situations in some countries, more countries defaulting on co -financing as their
payments increase, enhancing risk management, and growing fiscal pressure in
a numb er of donor markets. Looking back on 2014, I am proud of the progress
we have made in continuing to accelerate access to the wonder of immunisation.
Immunisation : more critical than ever
Our Board meeting comes at a time when the world is being reminded of the
grave threat still posed by infectious disease. Ebola , and its tragic impact on the
population of affected countries, has been prominent in the global news agenda.
But we are also witnessing a resurgence of measles, with many developed
countries exper iencing their highest number of cases in decades, while polio
continues to stubbornly elude the final push for elimination. These events are a
reminder of the power of immunisation and importance of Gavi .
Report of the Chief Executive Officer

Report to the Gavi Board
10 -11 December 2014

1



Board -2014 -Mtg -3-Doc 04
Report to the Board
10 -11 December 2014




SUBJECT : COMMITTEE CHAIR AND IFFIM BOARD REPORTS
Agenda item: 04
No paper

1 Board -2014 -Mtg -3-Doc 05
Report to the Board
10 -11 December 2014


Section A: Overview
1. Purpose of the report
1.1 The purpose of this report is to respond to the Executive Committee's
request to explore a potential role for Gavi, the Vaccine Alliance, in
supporting procurement and delivery of licensed Ebola vaccines as soon
as they become available. 1
1.2 This report submits recommendations for Gavi to support the global
response to decrease further Ebola -related mortality in the most affected
countries, particularly in Guinea, Liberia, and Sierra Leone; to contribute to
the recovery of health and immunisat ion systems in those countries most
impacted; to avert further economic disruption in affected areas of West
Africa; and to reduce the risks that both the current and potential future
Ebola outbreaks pose to human security and the wellbeing of populations
worldwide.
2. Recommendations
2.1 The Gavi Board is requested to:
(a) Approve a funding envelope (the ?Ebola Envelope?) from which the
Secretariat shall allot, in accordance with the principles of the Gavi
Programme Funding Policy and the processes (including delegations
to the CEO) and periods set out in Table 1 below, funding for Ebola
programmes, to:
i. Endorse new amounts for multi -year programme budgets for new
and existing programmes referred to in Table 1 for an aggregate
amount not exceeding US$ 390 million. (These endorsements
1 Given the global emergency of Ebola, this report and consultations were done in an 8 week accelerated period.
SUBJECT : ACCELERATING ACCESS TO EBOLA VACCINES AND
COUNTRY PERSPECTIVE
Report of: Robert Newman, Managing Director, Policy and Performance
Authored by: Alan Brooks, Alex de Jonquieres, Eliane Furrer, Stefano
Malvolti, Patience Musanhu, Aur?lia Nguyen
Agenda item: 05
Category: For Decision
Strategic goal: Affects all strategic goals

1



Board -2014 -Mtg -3-Doc 06
Report to the Board
10 -11 December 2014




SUBJECT : CHAIR?S REFLECTIONS ON THE DAY
Agenda item: 06
No paper

1



Board -2014 -Mtg -3-Doc 07
Report to the Board
10 -11 December 2014




SUBJECT : CHAIR?S OVERVIEW & P RESENTATION OF FILM
Agenda item: 07
No paper

1



Board -2014 -Mtg -3-Doc 08
Report to the Board
10 -11 December 2014


Section A: Overview
1. Purpose of the R eport
1.1 This report presents the final phase of the replenishment process in the
lead up to the Gavi pledging conference to be held on 26 -27 January 2015
in Berlin under the auspices of the German G7 presidency and under the
patronage of German Chancellor Angela Merkel.
2. Recommendations
2.1 This report is for information only.
3. Executive S ummary
3.1 Following the replenishment l aunch and the unveiling of the 2016 -2020
investment opportunity in Brussels , the final phase of the replenish ment
process was set in motion with 3 main objectives : (i) build a successful
global campaign led by Germany as a global champion; (ii) obtain a step
chan ge in donors contributions ; and (iii) carry out a successful pledging
conference leading to US$ 7.5 billion being raised on 26 -27 January 2015
in Berlin.
3.2 The global resource mobilisation strategy focuses on broadening the
donor base : moving from a high concentration in a small number of
leading donors to a n expanded group of 12 core donors whose
development aid priorities are closely aligned with those of Gavi . To
achieve this objective a 60 -day campaign was launched bringing together
a wide coalition of partners and champions to influence donors? decision -
making process in the midst of their budget processes in the Americas,
Asia -Pacific, and Europe .
SUBJECT: The Road to R eplenishment 2016 -2020
Report of: Marie -Ange Saraka -Yao, Director, Resource Mobilisation
Authored by: Marie -Ange Sar aka -Yao
Agenda item: 8
Category: For Information
Strategic goal: SG3 - Financing: global predictability/nat'l sustainability

1



Board -2014 -Mtg -3-Doc 09
Report to the Board
10 -11 December 2014


Section A: Overview
Purpose of the report 1.
1.1 This report informs the Gavi Alliance Board (?Board?) of the updated Gavi
financial forecast for 2011 -2020 ( version 10.0Fa ) , in Section B.
1.2 It requests the Board to approve two programme funding envelopes for
2015 to be allotted to individual programmes by the Secretariat , one for
Inactivated Polio Vaccine (IPV) programmes; the other for non -IPV
programmes , in Section D .
1.3 The report also informs the Board of programme e xpenditure in 2014, in
Section E.
Recommendations 2.
2.1 The GAVI Alliance Board is requested to :
201 5 Envelope for ?unrestricted? countries
Approve a 2015 Programme Funding Envelope for unrestricted countries
from which the Secretariat, under the Programme Funding Policy, shall
allot funding to programmes until 31 December 2015, to:
i. Endorse or adjust previously endorsed amounts of programme multi -
year budgets for existing programmes and new cash programmes for
an aggregate amount not exceeding US$ 2,452 million. (These
endorsements would constitute ackno wledgement of such budget
amounts at the time of allotment but would not constitute a funding
ap proval, decision, obligation or commitment of the GAVI Alliance or its
contributors.)
SUBJECT : FINANCIAL FORECAST A ND 2015 PROGRAMME FU NDING
ENVELOPE APPROVALS
Report of: Barry Greene, Managing Director, Finance and Operations
Authored by:
Tony Dutson, Senior Director Finance and Chief Accounting
Officer, Minzi Lam Meier, Head Financ ial Planning, Analysis
and Management Reporting
Agenda item: 09
Category: For Decision
Strategic goal: Alliance operations

1



Board -2014 -Mtg -3-Doc 11
Report to the Board
10 -11 December 2014


Section A: Overview
Purpose of the report 1.
1.1 Th is r eport provides an update on rece nt developments regarding India?s
plans to introduce Inactivated Polio Vaccine (IPV).
1.2 This report requests Board approval for Gavi to utilise additional funds, to
be provided by the Global Polio Eradication Initiative (GPEI), in order to
offer India catalytic support for the introduction of IPV.
Recommendations 2.
2.1 The Gavi Board is requested to:
(a) Note that the Global Polio Eradication Initiative (?GPEI?) considers that
timely introduction of IPV in India , a Tier 1 country, will be very
important in achieving the goals of the Polio Eradication & Endgame
Strategic Plan.
(b) Approve the recommendations of the November 2014 Independent
Review Committee (IRC) regarding the application for introduction of
IPV in India for the period 2015 -2018 (the ?India IPV Programme?)
subject to the following conditions:
i. All IRC requested recommendations being addressed;
ii. GPEI making available the full amount of financing required (the
?GPEI Amount?) to provide catalytic support for the first 12 months
of India ?s IPV Programme estimated to be up to US$ 50 million ;
and
SUBJECT : IPV IN INDIA
Report of: Hind Khatib -Othman, Managing Director, Country Programmes
Authored by: Dirk Gehl, Stefano Malvolti, Stephen Sosler, Emily Wootton
Agenda item: 11
Category: For Decision
Strategic goal: SG1 - Underused and new vaccines

1



Board -2014 -Mtg -3-Doc 13
Report to the Board
10 -11 December 2014


Section A: Overview
Purpose of the report 1.
1.1 In December 2012, the Board approved the business plan and budget for
2013 and 2014. For 2015, the final year of the current strategy period, a
one -year business plan is being developed with the aim of consolidating
the work started earlier in the period, supporting progress towards the
agreed targets and deliverables for the end of 2015, and preparing the
ground for the new paradigm envis ioned under the Gavi 2016 -2020
strateg ic framework .
1.2 This report provides the Board with an overview of the key programmatic
and budget aspects of the 2015 b usiness plan , the operating model to
implement it and the allocation of resources across the priority areas. It
also describes the step changes envisage d for the 2016 -20 17 period.
1.3 A summary of the business plan programme objectives, deliverables and
costs is included in Annex 1 of this document. Annex 2 provides the
background information for the adjustments in baseline and target for
some of Gavi?s business plan indicators. Annex 3 provides details of
Secretariat budget. Annex 4, provided by UNICEF Supply Division, details
the basis for the proposed procurement fee for 2015 . Additional
information on detailed deliverabl es and activities by partners are available
on m yGavi.
1.4 At its September meeting, t he Executive Committee reviewed and
endorsed the strategic direction and priorities for the business plan 2015
and the new principles and approaches foreseen for the 2016 -20 17
period.
SUBJECT: 2015 B USINESS PLAN AND BUDGET
Report of: Anuradha Gupta, Deputy CEO
Authored by:
Adrien de Chaisemartin, Tony Dutson, Ciara Goldstein, Barry
Greene, Minzi L am Meier, Robert Newman, Ricca
Ranariboana , Meegan Murray -Lopez
Agenda item: 13
Category: For Decision
Strategic goal: Affects all strategic goals

1



Board -2014 -Mtg -3-Doc 14
Report to the Board
10 -11 December 2014




SUBJECT : REVIEW OF DECISIONS
Agenda item: 14
No paper

1



Board -2014 -Mtg -3-Doc -A
Report to the Board
10 -11 December 2014


Section A: Overview
Purpose of the report 1.
1.1 This report aim s to update the Gavi Board on progress in 2014 in
implementing the Gavi Gender Policy as revised in 2013.
Recommendations 2.
2.1 This report is for information only.
Executive summary 3.
3.1 In June 2014, the Gavi Board approved a new strategic framework for the
Alliance for the period 2016 -2020 that calls for an increasing focus on
coverage and equity of immunisation. Whereas in the current strategy for
2011 -2015, Gavi?s commitment to gender appeared as an overarching
operating principle, in the new strategic framework gender has been more
concre tely embedded within the strengthened equity focus of the first two
strategic goal s, and anticipates corresponding goal -level indicators related
to gender and equity .
3.2 Since the last annual update to the Board, the Secretariat Gender Working
Group has im plemented a work plan of gender activities for 2014 and has
reported on a quarterly basis on those activities to the Executive Team
and to the Board via myGavi.
3.3 Key activities in 2014 related to further strengthening awareness and
understanding of gender a nd immunisation , as well as of the revised Gavi
Gender Policy, within the Secretariat and other bodies through training
sessions and additional analyt ic work; to engaging with key processes
such as the development of the 2016 -2020 strategy development proc ess
and the Grant Application and Monitoring Review process ; to
SUBJECT : ANNUAL REPORT ON IMPLEMENTATION OF THE
GENDER POLICY
Report of: Anuradha Gupta, Deputy CEO
Authored by: Meegan Murray -Lopez, Senior Executive Officer
Agenda item: A
Category: For Information
Strategic goal: Affects all strategic goals

Board-2014-Mtg-3-Doc Annex B



GAVI Alliance Board Meeting
10-11 December 2014
Starling Hotel, Geneva, Switzerland
Tuesday 9 December: Pre-Board meetings
Wednesday 10 December: 09.00-18.00 (Board meeting D ay One)
Thursday 11 December: 08.30-17.30 (Board meeting Da y Two)
Quorum: 14

Board and committee minutes


Annex Pages MINUTES
1-26 Board ? 18-19 June 2014
27 Board ? 22 September 2014
28-36 Executive Committee ? 23 September 2014
37-39 Executive Committee ? 6 November 2014 (Decision sli des)
40-44 Audit and Finance Committee ? 30 July 2014
45-49 Audit and Finance Committee ? 24 October 2014 (Deci sion slides)
50 Audit and Finance Committee ? 19 November 2014
51-52 Programme and Policy Cte ? 07-08 October 2014 (Agen da)
53-54 Programme and Policy Cte ? 10 November 2014 (Decisi on slides)
55-58 Governance Committee ? 31 October 2014 (Decision slides)
59-61 Investment Committee ? 12 September 2014
62 Investment Committee ? 12 November 2014 (Agenda)



Note
Minutes of Board and Committee meetings held since the Board meeting in Geneva in June
2014 are included in this document for ease of refe rence. Decision slides are included instead of
meeting minutes that are not yet approved. The agen da of a meeting is provided when no
decision was made and the minutes are not yet appro ved.

PPC -2014 -Mtg -02 1




G avi Alliance Board Meeting
10 -11 December 2014
Starling Hotel, Geneva, Switzerland



1. Chair?s report

1.1 Finding a quorum of members present, the meeting commenced at 9.00 Geneva
time on 10 December 2014. Dagfinn H?ybr?ten , Board Chair , chaired the
meeting except for the discussion in section 11 which was chaired by Geeta Rao
Gupta, Vice Chair.

1.2 The Board beg an in executive session and then commenced the open session at
11.15.

1.3 The Chair welcomed new Board members and alternate Board members. He
noted that there were a large number of seats turning over at this meeting . High
turnover can present a challenge f or sustained strategic dialogue but structured
and intensive onboarding can mitigate this challenge and he encouraged such
sessions to continue and for Board members and Alternate Board members to
attend .

1.4 The Chair noted the pending departures of a number of longstanding and
outstanding Board members. George W. Wellde, Jr, Investment Committee
Chair, had served as a Board member since the earliest days of the Vaccine
Fund. He had committed countless hours of voluntary service and had been a
distinct, clear, and bold voice at the table. Ashutosh Garg had served the Gavi
cause since 2006. His unique knowledge and experience had set a high
standard for future unaffiliated members. The Chair noted that these and other
departing members would be toasted at the di nner that evening.

1.5 The Chair recognised the service of Geeta Rao Gupta who was stepping down
as Vice Chair and Chair of the Governance Committee. Her intellect and
leadership had allowed her to serve in these roles with great distinction. Gavi
would continue to benefit from her insight as a continuing member of the Board
and Governance Committee.

1.6 The Chair welcomed Ren? Karsenti, Chair of the Board of the International
Finance Facility for Immunisation (IFFIm) and his colleagues from the IFFIm
Board.

1.7 Standing declarations of interest were tabled to the Board (Doc 1a in the Board
pack). The Chair noted several declarations related to the discussions on Ebola


Minutes

Gavi

Gavi

Gavi

IFFIm Report

Ren? Karsenti, Chair, IFFIm Board

Gavi Alliance Board Meeting
Geneva, Switzerland
10 December 2014


IFFIm update
2
? Funding Gavi
? IFFIm Sukuk issuance
? Making IFFIm even more efficient
Gavi Alliance Board meeting 10-11 December 2014 2

0

www.gavi.org
ACCELERATING ACCESS TO
EBOLA VACCINES AND
COUNTRY PERSPECTIVE
BOARD MEETING
Seth Berkley, Robert Newman, Aur?lia Nguyen
10 -11 D ecember 2014, Geneva
1

AGENDA
Process of generating Board recommendation

Funding landscape and Gavi capabilities

Four recommended areas for Gavi action

Financial implications

Risks



1
2
3
4
5

REMARQUE :
Pour modifier
l?image
pr?sente sur
cette
diapositive,
s?lectionnez
l?image, puis
supprimez -la.
Cliquez ensuite
sur l?ic?ne
Images dans
l?espace
r?serv? pour
ins?rer votre
propre image.

Professeur Awa Marie COLL SECK
Minister of Health and Social Action

December 2014
29 August 2014
Background and case profile
08 -august Brother's death
10 -august Brother's inhumation in Forecariah
11 -august Travel in a cab from Forecariah to Conakry
12 - august Travel by bus from Conackry to Dakar
13 -august Travel from Bus station to Sanitary district North
14 -august First Sickness signs
16 -august Check in a Health Center
26 -august
Diagnosis and Hospitalization at Fann Hospital
Informations on " Contact" & " Isolation
27 -august Sample and Confirmation of Ebola virus
Previous situation: Senegal had one (1) case

WHO template and recommendations

Gavi

Gavi

Gavi

Gavi